OverviewZydus Pharmaceuticals (Canada) Inc., located in Toronto, Ontario is a wholly owned subsidiary of Zydus Lifesciences limited, a global life-sciences company backed by pathbreaking scientific research and technological innovations, done with the patient in mind. The company plans to launch a wide range of oral solids, topicals and injectables in Canada.Our MissionAs a company, our vision, mission, and purpose exemplify our commitment to science and our dedication to care and nurturance. To unlock new possibilities in life-sciences through quality healthcare solutions that impact lives.Zydus Lifesciences LimitedZydus Lifesciences Limited, the parent company of Zydus Pharmaceuticals (Canada), Inc. is a fully integrated, global healthcare provider located in Ahmedabad, India. With a legacy of over 70 years, the company is driven by a passion for innovation and making a difference in the world of health and care. Zydus Lifesciences is India's fourth largest pharmaceutical company with more than 30 manufacturing plants worldwide and business operations in 55 countries including, India, the US, France, Spain, Brazil, Mexico, and South Africa. As one of the key players amongst pharmaceutical manufacturing companies, Zydus Lifesciences has manufacturing capabilities across the entire pharmaceutical value chain including formulations, APIs, vaccines, biosimilars, complex products, animal health products, and wellness products. From new chemical entities to vaccines, biosimilars, novel biologics, and niche technologies, Zydus is exploring different ideas to develop differentiated medicines for the future. Zydus Lifescience's ZyCoV-D vaccine was the world's first plasmid DNA vaccine to be approved for human use and is currently approved in India as a two-dose regimen for adults and children aged 12 years and above.